4
Changes in Ownership
Aquestive Therapeutics, Inc. Filed Acc 0001214659-26-014000
Chief Development Officer gave up 5,303 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Davis Matthew W. Chief Development Officer | 2026-11-10 | Shares withheld for taxes | −5,303 | $3.52 | $18,667 | 94,697 | D |
Loading xslF345X06/marketforms-74276.xml…